Roundtable Discussion: Considering End Commercialization Attributes Early in Development to Prevent Downstream Disruption
Time: 2:30 pm
day: Conference Day One
Details:
- How do we get cell therapies to become “mainstream” treatments?
- Can we tackle the issues of infrastructure by setting up a decentralized network in the US?
